P495: PHASE 2 STUDY OF ASTX727 (DECITABINE/CEDAZURIDINE) PLUS VENETOCLAX IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML) OR PREVIOUSLY UNTREATED, ELDERLY PATIENTS UNFIT FOR CHEMOTHERAPY.

Authors :: Abuasab, T.
Alvarado, Y.
Issa, G.
Islam, R.
Short, N.
Yilmaz, M.
jain, N.
Masarova, L.
Kornblau, S.
Jabbour, E.
Pemmaraju, N.
Montalban‐Bravo, G.
Pierce, S.
DiNardo, C.
Kadia, T.
Daver, N.
Konopleva, M.
Garcia‐Manero, G.
Ravandi, F.
Source :: HemaSphere; 2022 Supplement 3, Vol. 6, p394-395, 2p
Publication Year :: 2022

Full Text Access

Tools